FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dan Duda

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Yuhui Huang; Rakesh K Jain; Walid S Kamoun; Pierre Leblanc; John D Martin; Margaret R Martin; Lance L Munn; Jean Nezivar; Marek Ancukiewicz; Dan G Duda; Dai Fukumura; Peigen Huang; Elda Righi; Michael Santosuosso; Fabrizio Vianello; Jianping Yuan; Mark C Poznansky
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy.
Dan G Duda; Christopher G Willett
Going beyond systemic fluoropyrimidines with radiation therapy for rectal cancer: what should be the priority?
Sergey V Kozin; Lance L Munn; Dan G Duda; Rakesh K Jain
Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dan Duda (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yuhui Huang; Rakesh K Jain; Walid S Kamoun; Pierre Leblanc; John D Martin; Margaret R Martin; Lance L Munn; Jean Nezivar; Marek Ancukiewicz; Dan G Duda; Dai Fukumura; Peigen Huang; Elda Righi; Michael Santosuosso; Fabrizio Vianello; Jianping Yuan; Mark C Poznansky
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(43):17561-6.
2012: Dan G Duda; Christopher G Willett
Going beyond systemic fluoropyrimidines with radiation therapy for rectal cancer: what should be the priority?
Oncology (Williston Park, N.Y.) 2012;26(8):741-3.
2012: Sergey V Kozin; Lance L Munn; Dan G Duda; Rakesh K Jain
Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors?
Journal of the National Cancer Institute 2012;104(12):899-905.
2012: Chandrajit P Raut; Johanna Lahdenranta; Jeffrey A Morgan; Richard Quek; Marek Ancukiewicz; Yves Boucher; George D Demetri; Dan G Duda; J Paul Eder; Rakesh K Jain
Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948).
PloS one 2012;7(2):e26331.
2011: Sergey V Kozin; Lance L Munn; Dan G Duda; Rakesh K Jain
Is vasculogenesis crucial for the regrowth of irradiated tumours?
Nature reviews. Cancer 2011;11(7):532.
2011: Sachie Hiratsuka; Shom Goel; Walid S Kamoun; Yoshiro Maru; Dai Fukumura; Dan G Duda; Rakesh K Jain
Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(9):3725-30.
2011: Emmanuelle di Tomaso; Matija Snuderl; Walid S Kamoun; Dan G Duda; Pavan K Auluck; Ladan Fazlollahi; Ovidiu C Andronesi; Matthew P Frosch; Patrick Y Wen; Scott R Plotkin; E Tessa Hedley-Whyte; A Gregory Sorensen; Tracy T Batchelor; Rakesh K Jain
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.
Cancer research 2011;71(1):19-28.
2010: Dan G Duda; Annique M M J Duyverman; Mitsutomo Kohno; Matija Snuderl; Ernst J A Steller; Dai Fukumura; Rakesh K Jain
Malignant cells facilitate lung metastasis by bringing their own soil.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(50):21677-82.
2010: Tracy T Batchelor; Dan G Duda; Emmanuelle di Tomaso; Marek Ancukiewicz; Scott R Plotkin; Elizabeth Gerstner; April F Eichler; Jan Drappatz; Fred H Hochberg; Thomas Benner; David N Louis; Kenneth S Cohen; Houng Chea; Alexis Exarhopoulos; Jay S Loeffler; Marsha A Moses; Percy Ivy; A Gregory Sorensen; Patrick Y Wen; Rakesh K Jain
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2817-23.
2010: Christopher G Willett; Dan G Duda; Marek Ancukiewicz; Mira Shah; Brian G Czito; Rex Bentley; Martin Poleski; Hiroshi Fujita; Gregory Y Lauwers; Madeline Carroll; Douglas Tyler; Christopher R Mantyh; Paul Shellito; Daniel C Chung; Jeffrey W Clark; Rakesh K Jain
A safety and survival analysis of neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with standard chemoradiation in locally advanced rectal cancer.
The oncologist 2010;15(8):845-51.
2010: Dan G Duda; Christopher G Willett; Marek Ancukiewicz; Emmanuelle di Tomaso; Mira Shah; Brian G Czito; Rex Bentley; Martin Poleski; Gregory Y Lauwers; Madeline Carroll; Douglas Tyler; Christopher Mantyh; Paul Shellito; Jeffrey W Clark; Rakesh K Jain
Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer.
The oncologist 2010;15(6):577-83.
2009: Lei Xu; Dan G Duda; Emmanuelle di Tomaso; Marek Ancukiewicz; Daniel C Chung; Gregory Y Lauwers; Rekha Samuel; Paul Shellito; Brian G Czito; Pei-Chun Lin; Martin Poleski; Rex Bentley; Jeffrey W Clark; Christopher G Willett; Rakesh K Jain
Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.
Cancer research 2009;69(20):7905-10.
2009: A Gregory Sorensen; Tracy T Batchelor; Wei-Ting Zhang; Poe-Jou Chen; Priscilla Yeo; Meiyun Wang; Dominique Jennings; Patrick Y Wen; Johanna Lahdenranta; Marek Ancukiewicz; Emmanuelle di Tomaso; Dan G Duda; Rakesh K Jain
A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.
Cancer research 2009;69(13):5296-300.
2009: Andrew X Zhu; Dushyant V Sahani; Dan G Duda; Emmanuelle di Tomaso; Marek Ancukiewicz; Onofrio A Catalano; Vivek Sindhwani; Lawrence S Blaszkowsky; Sam S Yoon; Johanna Lahdenranta; Pankaj Bhargava; Jeffrey A Meyerhardt; Jeffrey W Clark; Eunice L Kwak; Aram F Hezel; Rebecca Miksad; Thomas A Abrams; Peter C Enzinger; Charlie S Fuchs; David P Ryan; Rakesh K Jain
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):3027-35.
2009: Christopher G Willett; Dan G Duda; Emmanuelle di Tomaso; Yves Boucher; Marek Ancukiewicz; Dushyant V Sahani; Johanna Lahdenranta; Daniel C Chung; Alan J Fischman; Gregory Y Lauwers; Paul Shellito; Brian G Czito; Terence Z Wong; Erik Paulson; Martin Poleski; Zeljko Vujaskovic; Rex Bentley; Helen X Chen; Jeffrey W Clark; Rakesh K Jain
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):3020-6.
2009: Rakesh K Jain; Dan G Duda; Christopher G Willett; Dushyant V Sahani; Andrew X Zhu; Jay S Loeffler; Tracy T Batchelor; A Gregory Sorensen
Biomarkers of response and resistance to antiangiogenic therapy.
Nature reviews. Clinical oncology 2009;6(6):327-38.
2009: Walid S Kamoun; Carsten D Ley; Christian T Farrar; Annique M Duyverman; Johanna Lahdenranta; Delphine A Lacorre; Tracy T Batchelor; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Dai Fukumura; A Gregory Sorensen; Rakesh K Jain
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(15):2542-52.
2009: Elizabeth R Gerstner; Dan G Duda; Emmanuelle di Tomaso; Peter A Ryg; Jay S Loeffler; A Gregory Sorensen; Percy Ivy; Rakesh K Jain; Tracy T Batchelor
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.
Nature reviews. Clinical oncology 2009;6(4):229-36.
2009: Jean Y Perentes; Dan G Duda; Rakesh K Jain
Visualizing anti-tumor immune responses in vivo.
Disease models & mechanisms 2009;2(3-4):107-10.
2009: Joshua Tam; Dan G Duda; Jean Y Perentes; Rehan S Quadri; Dai Fukumura; Rakesh K Jain
Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells.
PloS one 2009;4(3):e4974.
2008: Peigen Huang; Dan G Duda; Rakesh K Jain; Dai Fukumura
Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice.
Comparative medicine 2008;58(3):253-63.
2008: Patrick Au; Laurence M Daheron; Dan G Duda; Kenneth S Cohen; James A Tyrrell; Ryan M Lanning; Dai Fukumura; David T Scadden; Rakesh K Jain
Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels.
Blood 2008;111(3):1302-5.
2007: Elizabeth R Gerstner; Dan G Duda; Emmanuelle di Tomaso; Greg Sorensen; Rakesh K Jain; Tracy T Batchelor
Antiangiogenic agents for the treatment of glioblastoma.
Expert opinion on investigational drugs 2007;16(12):1895-908.
2007: Dan G Duda; Rakesh K Jain; Christopher G Willett
Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(26):4033-42.
2007: Christopher G Willett; Dan G Duda; Brian G Czito; Johanna C Bendell; jeffrey clark; Rakesh K Jain
Targeted therapy in rectal cancer.
Oncology (Williston Park, N.Y.) 2007;21(9):1055-65; discussion 1065, 1070, 1075 passim.
2007: Rakesh K Jain; Emmanuelle di Tomaso; Dan G Duda; Jay S Loeffler; A Gregory Sorensen; Tracy T Batchelor
Angiogenesis in brain tumours.
Nature reviews. Neuroscience 2007;8(8):610-22.
2007: Dan G Duda; Tracy T Batchelor; Christopher G Willett; Rakesh K Jain
VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects.
Trends in molecular medicine 2007;13(6):223-30.
2007: Christopher G Willett; Dan G Duda; Emmanuelle di Tomaso; Yves Boucher; Brian G Czito; Zeljko Vujaskovic; Gordana Vlahovic; Johanna C Bendell; Kenneth S Cohen; Herbert I Hurwitz; Rex Bentley; Gregory Y Lauwers; Martin Poleski; Terence Z Wong; erik paulson; Kirk A Ludwig; Rakesh K Jain
Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer.
Nature clinical practice. Oncology 2007;4(5):316-21.
2007: Dan G Duda; Kenneth S Cohen; David T Scadden; Rakesh K Jain
A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood.
Nature protocols 2007;2(4):805-10.
2007: Tracy T Batchelor; A Gregory Sorensen; Emmanuelle di Tomaso; Wei-Ting Zhang; Dan G Duda; Kenneth S Cohen; Kevin R Kozak; Daniel P Cahill; Poe-Jou Chen; Mingwang Zhu; Marek Ancukiewicz; Maciej M Mrugala; Scott Plotkin; Jan Drappatz; David N Louis; Percy Ivy; David T Scadden; Thomas Benner; Jay S Loeffler; Patrick Y Wen; Rakesh K Jain
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
Cancer cell 2007;11(1):83-95.
2006: Jeroen Hagendoorn; Timothy P Padera; Torunn I Yock; G Petur Nielsen; Emmanuelle di Tomaso; Dan G Duda; Thomas F Delaney; Henning A Gaissert; Jennifer Pearce; Andrew E Rosenberg; Rakesh K Jain; David H Ebb
Platelet-derived growth factor receptor-beta in Gorham's disease.
Nature clinical practice. Oncology 2006;3(12):693-7.
2006: Christopher G Willett; Sergey V Kozin; Dan G Duda; Emmanuelle di Tomaso; Kevin R Kozak; Yves Boucher; Rakesh K Jain
Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice.
Seminars in oncology 2006;33(5 Suppl 10):S35-40.
2006: Dan G Duda
Antiangiogenesis and drug delivery to tumors: bench to bedside and back.
Cancer research 2006;66(8):3967-70.
2006: Dan G Duda; Kenneth S Cohen; Sergey V Kozin; Jean Y Perentes; Dai Fukumura; David T Scadden; Rakesh K Jain
Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors.
Blood 2006;107(7):2774-6.
2006: Dan G Duda; Kenneth S Cohen; Emmanuelle di Tomaso; Patrick Au; Rachael J Klein; David T Scadden; Christopher G Willett; Rakesh K Jain
Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1449-53.
2006: Janka Kisucka; Catherine E Butterfield; Dan G Duda; Sarah C Eichenberger; Simin Saffaripour; Jerry Ware; Zaverio M Ruggeri; Rakesh K Jain; Judah Folkman; Denisa D Wagner
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(4):855-60.
2006: Rakesh K Jain; Dan G Duda; jeffrey clark; Jay S Loeffler
Lessons from phase III clinical trials on anti-VEGF therapy for cancer.
Nature clinical practice. Oncology 2006;3(1):24-40.
2005: Christopher G Willett; Yves Boucher; Dan G Duda; Emmanuelle di Tomaso; Lance L Munn; Ricky T Tong; Sergey V Kozin; Lucine Petit; Rakesh K Jain; Daniel C Chung; Dushyant V Sahani; Sanjeeva Kalva; Kenneth S Cohen; David T Scadden; Alan J Fischman; jeffrey clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Paul C Shellito; Mari Mino-Kenudson; Gregory Y Lauwers
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):8136-9.
2005: Rakesh K Jain; Patrick Au; Josh Tam; Dan G Duda; Dai Fukumura
Engineering vascularized tissue.
Nature biotechnology 2005;23(7):821-3.
2005: Mark Stroh; John P Zimmer; Dan G Duda; Tatyana S Levchenko; Kenneth S Cohen; Edward B Brown; David T Scadden; Vladimir P Torchilin; Moungi G Bawendi; Dai Fukumura; Rakesh K Jain
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo.
Nature medicine 2005;11(6):678-82.
2005: Dan G Duda; Rakesh K Jain
Pleiotropy of tissue-specific growth factors: from neurons to vessels via the bone marrow.
The Journal of clinical investigation 2005;115(3):596-8.
2004: Dan G Duda; Dai Fukumura; Lance L Munn; Michael F Booth; Edward B Brown; Peigen Huang; Brian Seed; Rakesh K Jain
Differential transplantability of tumor-associated stromal cells.
Cancer research 2004;64(17):5920-4.
2004: Dan G Duda; Dai Fukumura; Rakesh K Jain
Role of eNOS in neovascularization: NO for endothelial progenitor cells.
Trends in molecular medicine 2004;10(4):143-5.
2004: Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; jeffrey clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.
Nature medicine 2004;10(2):145-7.
2003: Dai Fukumura; Akira Ushiyama; Dan G Duda; Lei Xu; Josh Tam; V Krishna; K Chatterjee; Igor Garkavtsev; Rakesh K Jain
Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis.
Circulation research 2003;93(9):e88-97.